{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T11:05:01Z","timestamp":1743159901886,"version":"3.37.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.ejphar.2009.03.019","type":"journal-article","created":{"date-parts":[[2009,3,13]],"date-time":"2009-03-13T08:08:22Z","timestamp":1236931702000},"page":"49-54","source":"Crossref","is-referenced-by-count":16,"title":["Activity of new NOP receptor ligands in a rat peripheral mononeuropathy model: Potentiation of morphine anti-allodynic activity by NOP receptor antagonists"],"prefix":"10.1016","volume":"610","author":[{"given":"Taline V.","family":"Khroyan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Willma E.","family":"Polgar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Orduna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faming","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cris","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence","family":"Toll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nurulain T.","family":"Zaveri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2009.03.019_bib1","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1056\/NEJMra025411","article-title":"Opioid therapy for chronic pain","volume":"349","author":"Ballantyne","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2009.03.019_bib2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0304-3959(88)90209-6","article-title":"A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man","volume":"33","author":"Bennett","year":"1988","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2009.03.019_bib3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0006-8993(99)01393-1","article-title":"Loss of antiallodynic and antinociceptive spinal\/supraspinal morphine synergy in nerve-injured rats: restoration by MK-801 or dynorphin antiserum","volume":"831","author":"Bian","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2009.03.019_bib4","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0196-9781(00)00252-7","article-title":"Agonistic effects of the opioid buprenorphine on the nociceptin\/OFQ receptor","volume":"21","author":"Bloms-Funke","year":"2000","journal-title":"Peptides"},{"key":"10.1016\/j.ejphar.2009.03.019_bib5","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0014-2999(02)01833-2","article-title":"Up-regulation of ORL-1 receptors in spinal tissue of allodynic rats after sciatic nerve injury","volume":"447","author":"Briscini","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2009.03.019_bib6","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","article-title":"Quantitative assessment of tactile allodynia in the rat paw","volume":"53","author":"Chaplan","year":"1994","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.ejphar.2009.03.019_bib7","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejphar.2004.11.052","article-title":"Broad analgesic profile of buprenorphine in rodent models of acute and chronic pain","volume":"507","author":"Christoph","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2009.03.019_bib8","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0006-8993(01)02520-3","article-title":"The putative OP(4) antagonist, [Nphe(1)]nociceptin(1\u201313)NH(2), prevents the effects of nociceptin in neuropathic rats","volume":"905","author":"Corradini","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2009.03.019_bib9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0304-3940(00)01080-6","article-title":"Potentiation of morphine and clomipramine analgesia by cholecystokinin-B antagonist CI-988 in diabetic rats","volume":"286","author":"Coudore-Civiale","year":"2000","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2009.03.019_bib10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0304-3959(00)00304-3","article-title":"Spinal effect of the cholecystokinin-B receptor antagonist CI-988 on hyperalgesia, allodynia and morphine-induced analgesia in diabetic and mononeuropathic rats","volume":"88","author":"Coudore-Civiale","year":"2000","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2009.03.019_bib11","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.pain.2004.03.037","article-title":"Evidence for an exclusive antinociceptive effect of nociceptin\/orphanin FQ, an endogenous ligand for the ORL1 receptor, in two animal models of neuropathic pain","volume":"110","author":"Courteix","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2009.03.019_bib12","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0022-3565(24)37095-8","article-title":"Binding and in vitro activities of peptides with high affinity for the nociceptin\/orphanin FQ receptor, ORL1","volume":"283","author":"Dooley","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2009.03.019_bib13","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.pain.2007.08.033","article-title":"Pharmacologic management of neuropathic pain: evidence-based recommendations","volume":"132","author":"Dworkin","year":"2007","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2009.03.019_bib14","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0304-3959(98)00071-2","article-title":"Anti-hyperalgesic and anti-allodynic effects of intrathecal nociceptin\/orphanin FQ in rats after spinal cord injury, peripheral nerve injury and inflammation","volume":"76","author":"Hao","year":"1998","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2009.03.019_bib15","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1016\/j.lfs.2005.06.001","article-title":"Nociceptin\/orphanin FQ: pain, stress and neural circuits","volume":"77","author":"Heinricher","year":"2005","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2009.03.019_bib16","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/AJP.0b013e31815ca2b4","article-title":"Buprenorphine: new tricks with an old molecule for pain management","volume":"24","author":"Heit","year":"2008","journal-title":"Clin. J. Pain"},{"key":"10.1016\/j.ejphar.2009.03.019_bib17","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0022-3565(24)29586-0","article-title":"Comparison of pharmacological activities of buprenorphine and norbuprenorphine: norbuprenorphine is a potent opioid agonist","volume":"297","author":"Huang","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2009.03.019_bib18","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejphar.2006.12.015","article-title":"Anti-nociceptive and anti-allodynic effects of a high affinity NOP hexapeptide [Ac-RY(3-Cl)YRWR-NH2] (Syn 1020) in rodents","volume":"560","author":"Khroyan","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2009.03.019_bib19","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1124\/jpet.106.111997","article-title":"SR 16435 [1-(1-(bicyclo[3.3.1]nonan-9-yl)piperidin-4-yl)indolin-2-one], a novel mixed nociceptin\/orphanin FQ\/mu-opioid receptor partial agonist: analgesic and rewarding properties in mice","volume":"320","author":"Khroyan","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2009.03.019_bib20","doi-asserted-by":"crossref","first-page":"10331","DOI":"10.1523\/JNEUROSCI.23-32-10331.2003","article-title":"Buprenorphine-induced antinociception is mediated by mu-opioid receptors and compromised by concomitant activation of opioid receptor-like receptors","volume":"23","author":"Lutfy","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2009.03.019_bib21","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/377532a0","article-title":"Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor","volume":"377","author":"Meunier","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2009.03.019_bib22","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.pbb.2004.03.005","article-title":"Morphine and endomorphin-1 differently influence pronociceptin\/orphanin FQ system in neuropathic rats","volume":"78","author":"Mika","year":"2004","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2009.03.019_bib23","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0306-4522(96)00338-7","article-title":"Orphanin FQ is a functional anti-opioid peptide","volume":"75","author":"Mogil","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2009.03.019_bib24","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0304-3959(96)03282-4","article-title":"Enhancement of the antiallodynic and antinociceptive efficacy of spinal morphine by antisera to dynorphin A (1\u201313) or MK-801 in a nerve-ligation model of peripheral neuropathy","volume":"69","author":"Nichols","year":"1997","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2009.03.019_bib25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pain.2005.03.012","article-title":"Spinal and local peripheral antiallodynic activity of Ro64-6198 in neuropathic pain in the rat","volume":"116","author":"Obara","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2009.03.019_bib26","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0304-3940(95)12026-Z","article-title":"Inhibition by spinal morphine of the tail-flick response is attenuated in rats with nerve ligation injury","volume":"199","author":"Ossipov","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2009.03.019_bib27","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0014-2999(01)01308-5","article-title":"Opioids in chronic pain","volume":"429","author":"Przewlocki","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2009.03.019_bib28","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.2174\/1381612054865055","article-title":"Opioids in neuropathic pain","volume":"11","author":"Przewlocki","year":"2005","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejphar.2009.03.019_bib29","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jpainsymman.2006.05.013","article-title":"Nociceptin levels in the cerebrospinal fluid of chronic pain patients with or without intrathecal administration of morphine","volume":"32","author":"Raffaeli","year":"2006","journal-title":"J. Pain Symptom Mgmt."},{"key":"10.1016\/j.ejphar.2009.03.019_bib30","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1126\/science.270.5237.792","article-title":"Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor","volume":"270","author":"Reinscheid","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2009.03.019_bib31","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/sj.bjp.0707598","article-title":"Activities of mixed NOP and mu-opioid receptor ligands","volume":"153","author":"Spagnolo","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2009.03.019_bib32","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0304-3940(01)02095-X","article-title":"Changes in brain content of nociceptin\/orphanin FQ and endomorphin 2 in a rat model of neuropathic pain","volume":"311","author":"Sun","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2009.03.019_bib33","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0304-3940(03)00502-0","article-title":"Effect of JTC-801 (nociceptin antagonist) on neuropathic pain in a rat model","volume":"351","author":"Suyama","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2009.03.019_bib34","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/sj.bjp.0700942","article-title":"Bidirectional modulatory effect of orphanin FQ on morphine-induced analgesia: antagonism in brain and potentiation in spinal cord of the rat","volume":"120","author":"Tian","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2009.03.019_bib35","first-page":"2092","article-title":"Nociceptin or antinociceptin: potent spinal antinociceptive effect of orphanin FQ\/nociceptin in the rat","volume":"7","author":"Xu","year":"1996","journal-title":"Neuroreport"},{"key":"10.1016\/j.ejphar.2009.03.019_bib36","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0306-4522(97)00166-8","article-title":"Analgesic effect of intrathecally administered nociceptin, an opioid receptor-like1 receptor agonist, in the rat formalin test","volume":"81","author":"Yamamoto","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2009.03.019_bib37","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0304-3940(97)13475-9","article-title":"Effects of intrathecally administered nociceptin, an opioid receptor-like1 (ORL1) receptor agonist, on the thermal hyperalgesia induced by unilateral constriction injury to the sciatic nerve in the rat","volume":"224","author":"Yamamoto","year":"1997","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2009.03.019_bib38","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1124\/jpet.105.100859","article-title":"Buprenorphine activates mu and opioid receptor like-1 receptors simultaneously, but the analgesic effect is mainly mediated by mu receptor activation in the rat formalin test","volume":"318","author":"Yamamoto","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2009.03.019_bib39","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1124\/jpet.103.055848","article-title":"Modification of nociception and morphine tolerance by the selective opiate receptor-like orphan receptor antagonist (\u2013)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9- tetrahydro-5H-benzocyclohepten-5-ol (SB-612111)","volume":"308","author":"Zaratin","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2009.03.019_bib40","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1021\/jm034249d","article-title":"A novel series of piperidin-4-yl-1,3-dihydroindol-2-ones as agonist and antagonist ligands at the nociceptin receptor","volume":"47","author":"Zaveri","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2009.03.019_bib41","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1124\/jpet.102.046979","article-title":"Nociceptin\/orphanin FQ and its receptor-potential targets for pain therapy?","volume":"306","author":"Zeilhofer","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299909002404?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299909002404?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T10:35:32Z","timestamp":1739010932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299909002404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":41,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S0014299909002404"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2009.03.019","relation":{},"ISSN":["0014-2999"],"issn-type":[{"type":"print","value":"0014-2999"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}